Found: 39
Select item for more details and to access through your institution.
On the Rotational Intergrowth of Hierarchical FAU/EMT Zeolites.
- Published in:
- Angewandte Chemie International Edition, 2014, v. 53, n. 36, p. 9456, doi. 10.1002/anie.201402024
- By:
- Publication type:
- Article
Increasing Follow-up Outcomes of At-Risk Alcohol Patients Using Motivational Interviewing.
- Published in:
- Journal of Trauma Nursing, 2016, v. 23, n. 3, p. 165, doi. 10.1097/JTN.0000000000000200
- By:
- Publication type:
- Article
Strength and Plasticity of H- and Oxide- Terminated Cubic Si Nanocrystals.
- Published in:
- Microscopy & Microanalysis, 2014, v. 20, n. S3, p. 1460, doi. 10.1017/S1431927614009039
- By:
- Publication type:
- Article
Dosing Recommendation Based on the Effects of Different Meal Types on Pexidartinib Pharmacokinetics in Healthy Subjects: Implementation of Model‐informed Drug Development Strategy.
- Published in:
- Clinical Pharmacology in Drug Development, 2023, v. 12, n. 5, p. 475, doi. 10.1002/cpdd.1240
- By:
- Publication type:
- Article
Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 2, p. 407, doi. 10.1245/s10434-009-0784-y
- By:
- Publication type:
- Article
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.
- Published in:
- Journal of Pathology, 2014, v. 234, n. 2, p. 190, doi. 10.1002/path.4379
- By:
- Publication type:
- Article
On the Rotational Intergrowth of Hierarchical FAU/EMT Zeolites.
- Published in:
- Angewandte Chemie, 2014, v. 126, n. 36, p. 9610, doi. 10.1002/ange.201402024
- By:
- Publication type:
- Article
Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 3, p. 831, doi. 10.1007/s10637-019-00840-1
- By:
- Publication type:
- Article
Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas.
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4871, doi. 10.3390/cancers15194871
- By:
- Publication type:
- Article
Distribution and Rate of Myxoid Liposarcoma Spine Metastases: Impact on Surveillance Imaging.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 13, p. 8647, doi. 10.1245/s10434-023-14309-2
- By:
- Publication type:
- Article
Supporting patients in the transition to the revised pexidartinib dosing regimen: perspectives from the multidisciplinary clinical and allied health professional team.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02926-9
- By:
- Publication type:
- Article
A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
- Published in:
- Oncogene, 2001, v. 20, n. 6, p. 659, doi. 10.1038/sj.onc.1204139
- By:
- Publication type:
- Article
Datasets for reporting of soft‐tissue sarcoma: recommendations from the International Collaboration on Cancer Reporting (ICCR).
- Published in:
- Histopathology, 2023, v. 82, n. 5, p. 745, doi. 10.1111/his.14862
- By:
- Publication type:
- Article
Datasets for the reporting of primary tumour in bone: recommendations from the International Collaboration on Cancer Reporting (ICCR).
- Published in:
- Histopathology, 2023, v. 82, n. 4, p. 531, doi. 10.1111/his.14849
- By:
- Publication type:
- Article
TP53 mutations emerge with HDM2 inhibitor SAR405838 treatment in de-differentiated liposarcoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12609, doi. 10.1038/ncomms12609
- By:
- Publication type:
- Article
High electron mobility in thin films formed via supersonic impact deposition of nanocrystals synthesized in nonthermal plasmas.
- Published in:
- Nature Communications, 2014, v. 5, n. 12, p. 5822, doi. 10.1038/ncomms6822
- By:
- Publication type:
- Article
Clinical characteristics and treatment outcomes in six cases of malignant tenosynovial giant cell tumor: initial experience of molecularly targeted therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Exposure–response analysis of efficacy and safety for pexidartinib in patients with tenosynovial giant cell tumor.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 11, p. 1422, doi. 10.1002/psp4.12712
- By:
- Publication type:
- Article
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas: The ANNOUNCE Randomized Clinical Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Population Pharmacokinetic Analysis of Pexidartinib in Healthy Subjects and Patients With Tenosynovial Giant Cell Tumor or Other Solid Tumors.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 4, p. 480, doi. 10.1002/jcph.1753
- By:
- Publication type:
- Article
Evaluation of Potential Drug‐Drug Interaction Risk of Pexidartinib With Substrates of Cytochrome P450 and P‐Glycoprotein.
- Published in:
- Journal of Clinical Pharmacology, 2021, v. 61, n. 3, p. 298, doi. 10.1002/jcph.1734
- By:
- Publication type:
- Article
Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid Tumors.
- Published in:
- Journal of Clinical Pharmacology, 2020, v. 60, n. 5, p. 605, doi. 10.1002/jcph.1556
- By:
- Publication type:
- Article
A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 8, p. 1223, doi. 10.1002/cncr.29175
- By:
- Publication type:
- Article
Patient-derived sarcoma xenografts for individual-patient selection of chemotherapy-ready for prime time?
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 5, p. 738, doi. 10.1002/cncr.28476
- By:
- Publication type:
- Article
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors: results of a multicenter phase 2 trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Tivantinib (ARQ 197), a selective inhibitor of MET, in patients with microphthalmia transcription factor-associated tumors.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 23, p. 5894, doi. 10.1002/cncr.27582
- By:
- Publication type:
- Article
A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 21, p. 5403, doi. 10.1002/cncr.27526
- By:
- Publication type:
- Article
Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 6, p. 1649, doi. 10.1002/cncr.26409
- By:
- Publication type:
- Article
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial.
- Published in:
- Acta Orthopaedica, 2021, v. 92, n. 4, p. 493, doi. 10.1080/17453674.2021.1922161
- By:
- Publication type:
- Article
Pexidartinib Long‐Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e863, doi. 10.1002/onco.13629
- By:
- Publication type:
- Article
Perceptions of Oncologists About Sharing Clinic Notes with Patients.
- Published in:
- Oncologist, 2019, v. 24, n. 1, p. e46, doi. 10.1634/theoncologist.2018-0070
- By:
- Publication type:
- Article
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Predictors of Response to Targeted Therapies for Gastrointestinal Stromal Tumors.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2012, v. 136, n. 5, p. 483, doi. 10.5858/arpa.2011-0082-RA
- By:
- Publication type:
- Article
Apoptosis Induced by Differentiation or Serum Deprivation in an Immortalized Central Nervous System Neuronal Cell Line.
- Published in:
- Journal of Neurochemistry, 1996, v. 67, n. 5, p. 1908, doi. 10.1046/j.1471-4159.1996.67051908.x
- By:
- Publication type:
- Article
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-813
- By:
- Publication type:
- Article
Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article